(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Have gravitational waves provided the first hint of primordial black holes born during the Big Bang? - 2The Most Vital Crossroads in Olympic History
- 3IDF Givati Brigade soldier arrested, charged in suspected Iran espionage
- 4The most effective method to Pick the Right Material Organization: Fundamental Tips
- 5Tech giants accused of not complying with Australian social media ban
- Bavarian leader questions Germany's Eurovision participation
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Asia's Noteworthy Destinations: A Voyager's Aide
- The Force of Positive Reasoning: Day to day Attestations
- I visited every country by 25. Antarctica showed me how much I still hadn't seen.
- China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
- What are parents to do as doctors clash with Trump administration over vaccines?
- Remains of banker missing since 1999 found on California beach by family looking for seashells
- Nitty gritty Manual for Picking Agreeable Tennis shoes
